News

Mar 22, 2021

Sanofi Canada earns Gold-level gender parity certification for the second straight year

Feb 23, 2021

Health Canada approves DUPIXENT® (dupilumab injection) as the first biologic for the treatment of moderate-to-severe atopic dermatitis in children aged 6 to 11 years

Jan 28, 2021

Sanofi Canada launches Biogenius Grant for high schools, strengthening commitment to equity in the field of STEM learning

Jan 26, 2021

Sanofi Canada named to Forbes Canada's Best Employers list for 2021

Dec 18, 2020

Health Canada approves expanded indication for SOLIQUA®

Dec 8, 2020

Canadians living with multiple sclerosis find support during COVID-19 pandemic through dedicated social media network

Nov 17, 2020

DUPIXENT® (dupilumab injection) now approved by Health Canada for patients with severe asthma

Sep 22, 2020

Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine

Aug 18, 2020

DUPIXENT® (dupilumab injection) now approved by Health Canada for severe chronic rhinosinusitis with nasal polyposis

Jul 15, 2020

Sanofi Canada increases access to financial assistance for diabetes medications

Jul 14, 2020

DUPIXENT® (dupilumab) receives positive recommendation from INESSS for the treatment of moderate-to-severe atopic dermatitis in adolescents

Jul 8, 2020

SARCLISA™ (isatuximab for injection) now available in Canada for patients with relapsed and refractory multiple myeloma

Jun 17, 2020

Sanofi: Important Information on Plaquenil® and COVID-19

Apr 24, 2020

DUPIXENT® (dupilumab) receives positive recommendation from CADTH for moderate-to-severe atopic dermatitis

Apr 14, 2020

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

Apr 2, 2020

First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19

Mar 2, 2020

Cablivi® (caplacizumab) approved by Health Canada for adults living with acquired thrombotic thrombocytopenic purpura (aTTP)

Jan 30, 2020

Sanofi Canada named a Top Employer in Montreal for 2020, the third similar recognition in the last six months

Nov 22, 2019

Sanofi Canada named one of Canada's Top 100 Employers for 2020

Oct 22, 2019

Patients in Quebec now have access to DUPIXENT™ for the treatment of moderate-to-severe atopic dermatitis

Oct 18, 2019

Sanofi to conduct precautionary voluntary recall of Zantac OTC in Canada and the U.S.

Photos 1

Oct 1, 2019

"Pillars of Strength" photo exhibit opens to celebrate National Seniors Day with compelling images of Canadian Seniors

Sep 27, 2019

Health Canada approves Dupixent™ as the first biologic for the treatment of adolescents with moderate-to-severe atopic dermatitis

Sep 26, 2019

Sanofi Canada receives Gold-Level Parity Certification

Photos 1

Jun 11, 2019

Canadian employers underestimate the presence of chronic disease in the workforce

Apr 11, 2019

Health Canada issues Notice of Compliance with Conditions (NOC/c) for LibtayoTM (cemiplimab), the first and only biologic for the treatment of advanced cutaneous squamous cell carcinoma (CSCC)

Oct 17, 2018

Canadians are invited to join the conversation: Raise Your Hand for Diabetes

Oct 1, 2018

Sanofi aims to topple the flu as it marks National Seniors Day with a Guinness World Record attempt

Sep 27, 2018

Canadians living with diabetes in Ontario and Manitoba now have greater access to diabetes medicine

Sep 25, 2018

Health Canada approves Lovenox® for the prevention of blood clot formation in the extra-corporeal circulation during hemodialysis in patients with end stage kidney disease (ESKD)

Studies show that Lovenox® (enoxaparin sodium) is an alternative to conventional heparin in preventing clotting during hemodialysis

Jul 10, 2018

Sanofi denounces CADTH negative recommendation that could limit treatment options for Canadians with atopic dermatitis

Jul 3, 2018

Three Canadian Researchers Receive Sanofi–CARO Award for Research in Prostate Cancer Therapies

Jun 27, 2018

Sanofi presents results from the first head-to-head study comparing Toujeo® to insulin degludec

Jun 22, 2018

Sanofi Canada Lends Support in the Fight to Eradicate Tuberculosis in Canada

Jun 13, 2018

Canadian employers underestimate the proportion of their workforce with a chronic condition and its impact

Jun 8, 2018

Canadian science prodigy winner of prestigious international competition

May 16, 2018

Canadians living with diabetes can now access a new resource to help better manage their disease

Apr 12, 2018

Sanofi to invest €350 million in Canadian vaccine facility

Apr 12, 2018

Sanofi to invest €350 million in Canadian vaccine facility

* Expansion demonstrates company’s commitment to innovation and leadership in global public health

Apr 12, 2018

New tools, support and information on insulin use now available to Canadians living with Type 2 diabetes aiming to maintain healthy blood glucose levels

Apr 11, 2018

/R E P E A T -- Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility/

Apr 10, 2018

Media Advisory - Sanofi to announce significant investment in Canadian vaccine production facility

Mar 10, 2018

Praluent® (alirocumab) significantly reduced risk of cardiovascular events in high-risk patients, and was associated with lower death rate

Feb 23, 2018

Building bridges in the community

Sanofi Canada donates nearly $40,000 to Centraide of Greater Montreal as 2017 Season of Solidarity campaign comes to an end

Dec 12, 2017

The results of a recent study favour Toujeo® over degludec and real-world evidence confirms Toujeo®'s value

Oct 17, 2017

Insulin in People Living with Type 2 Diabetes: Initiation and Dosage

Oct 17, 2017

Insulin in People Living with Type 2 Diabetes: Initiation and Dosage

May 29, 2017

The 20th Anniversary of The Sanofi Canada Healthcare Survey reveals surprising facts

May 12, 2017

Université de Montréal Doctoral Student earns Global Nursing Innovation Award

May 1, 2017

Sanofi Genzyme Announces Approval of CerdelgaTM (eliglustat capsules) by Health Canada for Rare Genetic Condition